Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers

New England Journal of Medicine

Volumn 327, Issue 9, 1992, Pages 588-593

  Haddow, James E ^a   Palomaki, Glenn E ^a   Knight, George J ^a   Williams, Josephine ^a   Pulkkinen, Andrea ^a   Canick, Jacob A ^b   Saller, Devereux N ^b   Bowers, Gail Barsel ^b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADOLESCENT; ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; ECHOGRAPHY; ESTRIOL BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

EID: 0026645888     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199208273270902     Document Type: Article

References (16)

1. Hook EB. Down syndrome: frequency in human populations and factors pertinent to variation in rates. In: de la Cruz FF, Gerald PS, eds. Trisomy 21 (Down syndrome): research perspectives. Baltimore: University Park Press, 1981:3–18.
2. National Center for Health Statistics. Vital statistics of the United States, 1988. Vol. 1. Natality. Washington, D.C.: Government Printing Office, 1990:89. (DHHS publication no. (PHS) 90–1100.)
3. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984; 148: 886–94.
4. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984; 1: 926–9.
5. DiMaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MJ. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 1987; 317: 342–6.
6. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Combining maternal serum α-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. Am J Obstet Gynecol 1989; 160: 575–81.
7. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987; 7: 623–30.
8. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988; 95: 330–3.
9. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883–7.
10. Cuckle HS, Wald NJ. Screening for Down's syndrome. In: Lilford RJ, ed. Prenatal diagnosis and prognosis. London: Butterworth, 1990:67–92.
11. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387–402.
12. Wald NJ, Cuckle HS. Recent advances in screening for neural tube defects and Down's syndrome. Baillieres Clin Obstet Gynaecol 1987; 1: 649–76.
13. Knight GJ. Alpha-fetoprotein. In: Pesch AJ, Kaplan L, eds. Methods in clinical chemistry. St. Louis: C.V. Mosby, 1987:459–65.
14. Canick JA. Screening for Down syndrome using maternal serum alpha-fetoprotein, unconjugated estriol and HCG. J Clin Immunoassay 1990; 13: 30–3.
15. Cuckle HS, Wald NJ. The effect of estimating gestational age by ultrasound cephalometry on the sensitivity of alpha-fetoprotein screening for Down's syndrome. Br J Obstet Gynaecol 1987; 94: 274–6.
16. Canick JA, Palomaki GE, Osathanondh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990; 10: 546–8.